Stock 1BT ENLIVEX THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Enlivex Therapeutics Ltd. Deutsche Boerse AG

Equities

1BT

IL0011319527

Market Closed - Deutsche Boerse AG
Other stock markets
 02:01:06 2024-07-11 am EDT 		5-day change 1st Jan Change
1.26 EUR +2.44% Intraday chart for Enlivex Therapeutics Ltd. +5.00% -45.22%
Jun. 30 Enlivex Therapeutics Ltd.'s Equity Buyback announced on August 30, 2023 has expired. CI
Jun. 24 Enlivex Therapeutics Says First Patient Dosed in Phase 1/2 Thumb Osteoarthritis Trial MT

Evolution of the average Target Price on Enlivex Therapeutics Ltd.

Price target over the last 5 years

History of analyst recommendation changes

0c52aaa9a1fa30bfcdeb6cec6.-HFFjxg0xJ2u--sJllp9DaoahidHwUzvXRdTYNN9YRI.yxAu1V1Mh_H5kIVwxjQNSO9A5WR3h3muOnU5WL82Bn-COQK4SXH8r_q3og~50f86bc34e0d27ffa57eae9b455c431f

Analyst Recommendations on Enlivex Therapeutics Ltd.

HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating MT
HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating MT
HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating MT
HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.4 USD
Average target price
6 USD
Spread / Average Target
+328.57%
High Price Target
6 USD
Spread / Highest target
+328.57%
Low Price Target
6 USD
Spread / Lowest Target
+328.57%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Enlivex Therapeutics Ltd.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. ENLV Stock
  4. 1BT Stock
  5. Consensus Enlivex Therapeutics Ltd.